Member Info for ROCKZ

Some of the criticism and conspiracy theories aimed at Bill Gates during this pandemic have been ludicrous.
He has held a long term interest in the subject and It would look great for him to be involved in the creation of a therapy for these diseases.

Laura Fonda: 4.4% Ownership in Tiziana life sciences.
From LinkedIn: Senior Business Planner-Partner Incentives & ISV Strategy- Microsoft
Bill Gates gave an interview in the last couple of days telling how the single therapeutic he was most excited about was monoclonal antibodies.
Is this just a coincidental link?
Tiziana found it rather easy to raise $57million, almost with a click of the fingers.

Totally agree regarding negative comments, no problem with people questioning anything and hopefully this message board can allay those fears.

Volumes good in the US again. Just overtaken our daily volume within the first hour again.

Seadoc, good stuff. Keep shorting on the dips all the way to £5 and you’ll be a wealthy man

Shorts might struggle to get a foothold here. Who’s going to lend them the shares with the record date imminent? Too messy at the moment IMO.
In the future, yes possibly and I assume they will be lining up for post demerger.
No doubt Gabrielle has been wise enough to receive some short term assurances from the investors who purchased today linked to the RNS.

Foralumab has entered the race left of field. Don’t forget that history tells us many drugs were discovered accidentally. Viagra was discovered by Pfizer after originally being a failed treatment for angina.

Tiziana has 3 facets to its Covid play now. Foralumab, Anti IL6r and the nebuliser. If one of these drugs or a combination comes it will be mega.

Galactico, the US have invested because of the potential Covid19 treatment. The buying volume date over there tells us that, it’s off the scale.

No mention of the ATM’s being extended in that 4th RNS today.
If they were to be extended I would have expected an RNS to announce the extension.
So can we assume ATM’s have ended for now?
Even smaller free float as previously mentioned.

The yanks are mad for the Covid aspect. Every time there’s a Covid related RNS the SP hits new highs. Kunwar pushes it extremely well but to have Dr Howard Weiner from Harvard Medical school pushing it too....well....it just adds even more gravitas.
Top day, top week. Long and strong, long and strong.

Foralumab- The potential here is frightening, so versatile. No wonder Gabrielle and Kunwar refer to it as ‘the jewel in the crown’

Fantastic viewing, thoroughly enjoyed that. Great to see the CEO and founder so excited and invested in this company. Updates are great and it really feels like their finger is on the pulse which is massively reassuring as a shareholder.
StemprintER to launch in Europe next year, Italy first.

Another steady day in TILS. I’m expecting a morning RNS tomorrow, not sure what it will be though. Anything related to Covid19 and it will send this into orbit both sides of the pond. Like I said at the weekend, the buying volume in the US shows the yanks are mad for the Covid play. I’m not sure the penny has quite dropped for them in terms of Tizianas other assets.
That alone gives me a lot of confidence that this share is still undervalued. Enjoy the ride.

The Accustem part of the interview is new news.
First time it has been confirmed by the company.
Well done to that person who suggested Accustem all those weeks ago.

I’ve been looking at the historical data of recent months. It’s pretty clear that the main company attribute that interests the US is the Covid treatment. The volume on the 11th March and 9th April related to Covid RNS updates is incomparable to any other updates, 9/12 times the standard high.
Trump has gone on record saying he preferred the concept of therapeutic therapies for COVID-19 over vaccines and it appears the US buyers agree, can’t get enough.
If Gabrielle really wants to get the SP moving this week maybe he’ll drop an RNS with an update on this. That would really be interesting.
If not, maybe he’ll save it for in and around the demerger to prevent any retreat in the SP.

Reid, I also find it interesting to know peoples strategies.
I think there’s a lot of shares being held by holders on this page alone who have brought on news and made this share the bulk of their portfolio.
I’m looking to hold long term with 55,000 shares. By long term I mean 2-3 years which some would argue isn’t long term in pharma terms.
I topped up in the week at 174p, £2k’s worth which I will probably just play around with and trade the dips.

Just catching up with the posts. It’s getting a bit touchy on this page, I think some people need to chill a bit.
I anticipate we’re about to see one of the finest weeks in Tiziana’s history, enjoy the ride.

Good to see you back in Slift, enjoy the posts. I’m still holding here but did decant some into TILS and HUR about 3 weeks ago as I feared we could get stuck around these levels. Hopefully get a rise from HUR then move some back over to here.
Looking to top up here in any case upon availability of funds.

Always believes innnnn.........da da GOLD.
I think you could miss that sharp rise once they announce record date..
I’m expecting 30/40 percent that day but maybe a bump or two before then.
What do others think we’ll see on the day of the record date announcement?